CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients
Proton and photon therapy in managing hematological malignancies
Current and potential PI3K and BTK inhibitors for CLL
Safety of ponatinib in chronic-phase chronic myeloid leukemia (CML) patients
Michael J. Mauro
What influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?